Skip to main content

Advertisement

SpringerLink
Log in

Subcutaneous nodules secondary to exenatide once weekly: clinical and histological findings

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. DeYoug MB, MacConell L, Sarin V, Trautmann M, Herbert P (2011) Encapsulation of exenatide in poly-(L, L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther 13:1145–1154

    Article  Google Scholar 

  2. Grossman S (2014) Pathophysiological and pharmacological rationale for the use of exenatide once weekly in patients with type 2 diabetes. Adv Ther 31:247–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shan SJ, Guo Y (2014) Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site. Am J Dermatopathol 36:510–512

    Article  PubMed  Google Scholar 

  4. Boysen NC, Stone MS (2014) Eosinophil-rich granulomatous panniculitis caused by exenatide injection. J Cutan Pathol 41:63–65

    Article  PubMed  Google Scholar 

  5. Andrés R, Barrios SB, Fernández LE, Santos BA (2014) Exenatide-induced eosinophil-rich granulomatous panniculitis: a novel case showing injected microspheres. Am J Dermatopathol 37:801–802

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departmant of Endocrinology, Instituto Portugues de Oncologia de Lisboa, Rua Professor Lima Basto, 1099-023, Lisbon, Portugal

    Sara Donato

  2. Departmant of Medicina, Hospital Pulido Valente, Alameda das Linhas de Torres, 117, 1769-001, Lisbon, Portugal

    Dora Sargento

  3. Clínica Universitária de Dermatologia de Lisboa, Hospital de Santa Maria – CHLN, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal

    Luis Soares-de-Almeida & Luis Uva

Authors
  1. Sara Donato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dora Sargento
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Soares-de-Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luis Uva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara Donato.

Ethics declarations

Conflict of interest

The authors state no conflict of interest, and all authors have received no payment to perform this work.

Ethical standard

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Human and animal rights

The authors declare that the procedures were followed according to the regulations established by the Clinical Research and Ethics Committee and to the Helsinki Declaration of the World Medical Association.

Informed consent

The authors declare having followed the protocols in use at their working center regarding patient’s data publication.

Additional information

Managed by Massimo Federici.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donato, S., Sargento, D., Soares-de-Almeida, L. et al. Subcutaneous nodules secondary to exenatide once weekly: clinical and histological findings. Acta Diabetol 53, 681–682 (2016). https://doi.org/10.1007/s00592-015-0827-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-015-0827-8

Keywords

Search

Navigation